首页 | 本学科首页   官方微博 | 高级检索  
     

低分子肝素钠联合丹奥治疗脑梗死疗效观察
引用本文:陈彦龙,王志远. 低分子肝素钠联合丹奥治疗脑梗死疗效观察[J]. 医学理论与实践, 2006, 19(3): 255-256
作者姓名:陈彦龙  王志远
作者单位:湖北省英山县人民医院,438700
摘    要:目的:观察低分子肝素钠联合丹奥(注射用奥扎格雷钠)治疗急性脑梗死(ACI)的疗效和不良反应。方法:104例ACI患者随机分为治疗组和对照组各52例,两组均常规应用低分子右旋糖酐500mL加维脑路通400mg静滴,1次/d。治疗组在此基础上加用低分子肝素钠5000U皮下注射,1次/d,丹奥80mg静滴,1次/d,疗程均为2周。观察两组患者治疗前后神经功能缺损评分,血小板聚集率的变化。结果:治疗组的总有效率及治疗后血小板聚集率与对照组比较,差异有显著性(P<0.05),治疗组神经功能缺损评分与对照组比较差异有极显著性(P<0.01)。结论:低分子肝素钠联合丹奥对急性脑梗死有较好的疗效,无明显不良反应。

关 键 词:脑梗死  低分子肝素钠  丹奥  疗效
文章编号:1001-7585(2006)03-0255-02
收稿时间:2005-08-03
修稿时间:2005-08-03

Clinical Observation of Low Molecular-Weight Heparin Sodium Combined with Dan''''ao in Treating Cerebral Infarction
CHEN Yan-long,WANG Zhi-yuan. Clinical Observation of Low Molecular-Weight Heparin Sodium Combined with Dan''''ao in Treating Cerebral Infarction[J]. The Journal of Medical Theory and Practice, 2006, 19(3): 255-256
Authors:CHEN Yan-long  WANG Zhi-yuan
Abstract:Objective: To observe clinical effect and side-effect of low molecular-weight heparin(LMWH) sodium combined with dan'ao(Ozagrel) in treating acute cerebral infarction(ACI).Methods: 104 cases of ACI were allocated randomly into two groups:treatment group and control group(52 cases in every group).The treatment group was given 5000U LMWH subcutaneously,once a day;80mg of dan'ao intravenously,once a day.The changes of the neurological deficit scores and platelet aggregation rate after treatment were observed in both groups.Results:The defference of total effective rate and platelet aggregation rate in the treatment group was significant compared to the control group(P<0.05),the neurological deficit scores of treatment group decreased very significantly,compared to the control group(P<0.01).Conclusion:LMWH combined with dan'ao is effective in treatment of ACI,without obvious side-effect.
Keywords:Cerebral infarction  Low molecular-weight heparin sodium  Dan'ao  Curative effect
本文献已被 CNKI 维普 万方数据 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号